Article
Identification and Verification of Immune Subtype-Related lncRNAs in Clear Cell Renal Cell Carcinoma
2 Jun 2022
Abstract excerpt
Background: According to clinical study results, immune checkpoint blockade (ICB) treatment enhances the survival outcome of patients with clear cell renal cell carcinoma (ccRCC). Previous research has divided ccRCC patients into immune subtypes with distinct ICB response rates. However, the study on the association between lncRNAs and ccRCC immune subtypes is lacking. Methods: Differentially expressed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
